Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effectiveness, Safety and Tolerability of the ContraMed VeraCept Intrauterine Copper Contraceptive for Long-Acting Reversible Contraception

NCT02446821 is registered in ClinicalTrials.gov with Sebela Women's Health Inc. as lead sponsor.

NCT NCT02446821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02446821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effectiveness, Safety and Tolerability of the ContraMed VeraCept Intrauterine Copper Contraceptive for Long-Acting Reversible Contraception
Lead sponsor
Sebela Women's Health Inc.
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2015
Completion date
March 22, 2019
Enrollment
286 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

contraception